SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-20-000020
Filing Date
2020-02-06
Accepted
2020-02-06 08:52:49
Documents
5
Period of Report
2020-02-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dare8-k.htm 8-K 26580
2 EXHIBIT 99.1 ex991.htm EX-99.1 10255
3 ex991001.jpg GRAPHIC 226878
4 ex991002.jpg GRAPHIC 309319
5 ex991003.jpg GRAPHIC 114525
  Complete submission text file 0001401914-20-000020.txt   934561
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 20581122
SIC: 2834 Pharmaceutical Preparations